Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development
Philadelphia, PA – Chimeron Bio, a Philadelphia-headquartered biotech company, has received a 2024 National Institutes of Health’s Small Business Innovation Research Innovative Concept Award through the National Cancer Institute. The funding will support Chimeron Bio’s program developing a cancer vaccine against an inherited form of colorectal cancer. Chimeron Bio will seek to develop a specialized…
read more